Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol. 2010 Jun; 117(3):440-5.

View in: PubMed